GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 206 filers reported holding GENMAB A/S in Q2 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $10,291,898 | 3.87% |
| Arlington Capital Management, Inc. | 26,115 | $1,106,754 | 1.24% |
| Dorsey Wright & Associates | 87,451 | $3,706,173 | 1.08% |
| Hardman Johnston Global Advisors LLC | 604,982 | $25,639,137 | 1.00% |
| TORRAY INVESTMENT PARTNERS LLC | 128,564 | $5,448,542 | 0.98% |
| Yorktown Management & Research Co Inc | 16,600 | $703,508 | 0.86% |
| First Light Asset Management, LLC | 160,263 | $6,791,946 | 0.63% |
| KLR INVESTMENT ADVISORS, LLC | 12,604 | $534,158 | 0.44% |
| Campbell & CO Investment Adviser LLC | 42,851 | $1,816,025 | 0.43% |
| Integrated Investment Consultants, LLC | 15,946 | $675,791 | 0.23% |